Health Technology/clinical-trials

Pilot RCT Tests WhatsApp-Based Smoking Cessation in Community Settings — Novel Mobile Health Approach for Primary Care

247 Health News Editorial

·

12 Apr 2026

·

4 min read

·clinical-trials

A pilot RCT in Singapore is testing WhatsApp-based smoking cessation support in community settings, combining brief advice with mobile messaging. This innovative approach could transform how primary care delivers accessible cessation support.

Originally reported by ClinicalTrials.gov

References

  1. 1.Babb, S., Malarcher, A., Schauer, G., Asman, K., & Jamal, A. (2017). Quitting smoking among adults—United States, 2000–2015. Morbidity and Mortality Weekly Report, 65(52), 1457-1464. https://doi.org/10.15585/mmwr.mm6552a1
  2. 2.Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018). Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews, 5(5), CD000146. https://doi.org/10.1002/14651858.CD000146.pub5
  3. 3.National University of Singapore. (2024). Mobile-assisted Brief Intervention for Smoking Cessation in Community-based Setting: a Pilot Randomised Controlled Trial. ClinicalTrials.gov. NCT07375459. https://clinicaltrials.gov/study/NCT07375459
  4. 4.Naughton, F. (2017). Delivering smoking cessation support to pregnant women via text message: considerations for developing and testing interventions. Nicotine & Tobacco Research, 19(10), 1134-1144. https://doi.org/10.1093/ntr/ntw204
  5. 5.Whittaker, R., McRobbie, H., Bullen, C., Rodgers, A., Gu, Y., & Dobson, R. (2019). Mobile phone text messaging and app‐based interventions for smoking cessation. Cochrane Database of Systematic Reviews, 10(10), CD006611. https://doi.org/10.1002/14651858.CD006611.pub5
  6. 6.World Health Organization. (2023). WHO Report on the Global Tobacco Epidemic 2023: Protect people from tobacco smoke. World Health Organization. https://www.who.int/publications/i/item/9789240070905
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service